These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
195 related items for PubMed ID: 3327350
1. The difficult decision when to discontinue multidrug therapy in leprosy. Kato L. Acta Leprol; 1987; 5(4):279-82. PubMed ID: 3327350 [No Abstract] [Full Text] [Related]
2. Drug resistance and multi-drug therapy in leprosy. Chatterjee BR. Lepr India; 1982 Jul; 54(3):402-11. PubMed ID: 6757576 [No Abstract] [Full Text] [Related]
5. Whither short-course chemotherapy for leprosy? Grosset J. Indian J Lepr; 1997 Jul; 69(2):119-20. PubMed ID: 9290962 [No Abstract] [Full Text] [Related]
6. [New trends in the treatment of leprosy]. Koźmińska-Kubarska A. Pol Tyg Lek; 1983 Nov 14; 38(46):1439-41. PubMed ID: 6374636 [No Abstract] [Full Text] [Related]
7. Skin smear examination in relation to multidrug therapy campaigns. Bhatia VN. Indian J Lepr; 1987 Nov 14; 59(1):75-9. PubMed ID: 3302062 [No Abstract] [Full Text] [Related]
8. [Antibacterial chemotherapy in leprosy: principles, objectives and recommendations]. Sansarricq H. Acta Leprol; 1986 Nov 14; 4(3):355-62. PubMed ID: 3551474 [No Abstract] [Full Text] [Related]
10. New developments in the chemotherapy of leprosy. Freerksen E. Lepr India; 1983 Jan 14; 55(1):122-32. PubMed ID: 6348410 [No Abstract] [Full Text] [Related]
11. Problems of multidrug therapy. Ramu G. Indian J Lepr; 1991 Jan 14; 63(3-4):435-45. PubMed ID: 1804896 [No Abstract] [Full Text] [Related]
12. Single-dose treatment for paucibacillary leprosy; feasibility of long-term follow up. Ganapati R, Revankar CR, Pai VV, Kingsley S. Int J Lepr Other Mycobact Dis; 1999 Sep 14; 67(3):308-9. PubMed ID: 10575413 [No Abstract] [Full Text] [Related]
13. Single dose multidrug therapy for single lesion paucibacillry leprosy. Salafia A. Indian J Lepr; 1998 Sep 14; 70(2):216-9; author reply 219-21. PubMed ID: 9724861 [No Abstract] [Full Text] [Related]
14. Single-dose treatment for paucibacillary leprosy; field implications. Revankar CR, Pai VV, Samy MS, Ganapati R. Int J Lepr Other Mycobact Dis; 1999 Sep 14; 67(3):312-4. PubMed ID: 10575415 [No Abstract] [Full Text] [Related]
15. Dapsone drug resistance in the MDT era. Roche PW, Neupane KD, Failbus SS, Butlin CR. Int J Lepr Other Mycobact Dis; 2000 Sep 14; 68(3):323-5. PubMed ID: 11221097 [No Abstract] [Full Text] [Related]
16. Single-dose treatment for paucibacillary leprosy; clinical problems and management. Pai VV, Bulchand HO, Revankar CR, Ganapati R. Int J Lepr Other Mycobact Dis; 1999 Sep 14; 67(3):310-2. PubMed ID: 10575414 [No Abstract] [Full Text] [Related]
17. Rifampicin resistant leprosy: a review and a research proposal of a pilot study. Ji B. Lepr Rev; 2002 Mar 14; 73(1):2-8. PubMed ID: 11969122 [No Abstract] [Full Text] [Related]
18. Treatment regimens for leprosy. Katoch VM. Indian J Lepr; 2008 Mar 14; 80(4):2p preceding 315. PubMed ID: 20329379 [No Abstract] [Full Text] [Related]
19. Response to treatment by multidrug regimens in the THELEP controlled clinical drug trials. Subcommittee on Clinical Trials of the Chemotherapy of Leprosy (THELEP) Scientific Working Group of the UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases. Lepr Rev; 1996 Dec 14; 67(4):260-79. PubMed ID: 9033197 [Abstract] [Full Text] [Related]
20. Multidrug therapy--the pathway for global leprosy elimination. al-Qubati Y, al-Kubati AS. Indian J Lepr; 2000 Dec 14; 72(4):477-90. PubMed ID: 11212482 [Abstract] [Full Text] [Related] Page: [Next] [New Search]